OVXA.IR
Ovoca Bio plc [OVXA.IR] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
OVXA.IR Stock Summary
Top 10 Correlated Stocks
OVXA.IR
In the News
OVXA.IR Financial details
Company Rating
-
Market Cap
407.82K
Income
-1.95M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
5
Optionable
No
Shortable
Yes
Earnings
-
P/E
-0.15
Forward P/E
-
PEG
0.02
P/S
-
P/B
0.11
P/C
-
P/FCF
-0.16
Quick Ratio
2.09
Current Ratio
2.81
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.02
EPS next Y
-
EPS next Q
-
EPS this Y
2.08%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-60%
ROE
-53%
ROC
-0.73%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.01-0.13
52W High
-
52W Low
-
RSI
14
Rel Volume
33.61
Avg Volume
1.42K
Volume
47.77K
Perf Week
0%
Perf Month
-63.79%
Perf Quarter
10.53%
Perf Half Y
90.91%
-
-
-
-
Beta
0.681
-
-
Volatility
0%, 0.01%
Prev Close
0%
Price
0.0105
Change
0%
Company Profile
- Volume Average 1.42K
- Market Capitalization 407.82K
- Employee 5
- CEO Mr. Kirill Andreyevich Golovanov
- Headquarters Dublin,IE
- IPO Date 2000-06-27
-
Website
https://ovocabio.com 
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
